Compare Progressive Corp (PGR) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Progressive Corp vs Stryker Corporation — how do they compare? Progressive Corp trades at $215.8 (market cap $125.23B), while Stryker Corporation trades at $277.44 (market cap $105.63B). The key difference: Progressive Corp is the larger of the two by market cap, and Stryker Corporation pays the higher dividend (1.28%). Which is the better fit depends on your goals.
| PGR | SYK | |
|---|---|---|
Market Cap | $125.23B | $105.63B |
Sector | Financials | Technology |
52-Week High | $248.80 | $388.79 |
52-Week Low | $190.40 | $275.39 |
Enterprise Value | $133.44B | $117.10B |
Dividend Yield | 0.19% | 1.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Progressive (PGR) trades at $214.9, down 1.85% today, with a bearish technical signal and neutral oscillators. The stock shows strong fundamentals with a P/E of 10.78, net income margin of 12.85%, and ROE of 34.94%, supported by revenue growth from $49.6B in 2022 to $87.6B in 2025. Recent earnings beat expectations in Q4 2025 and Q2 2026, but missed in Q1 2026. News highlights competition in auto insurance and telematics advantages.
Outlook is mixed: analyst consensus targets $231.18 with 38.1% buy ratings, but technical weakness and competitive pressures pose risks. Investment opportunity lies in valuation discounts and operational strength, though expense increases and market volatility require caution.
Stryker (SYK) is trading at $276.43, down 8.81% over 24 hours, with a bearish technical signal from moving averages but bullish oscillators. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Strong fundamentals include a net income margin of 14.43% and ROE of 16.51%, though valuation ratios like a P/E of 28.65 are elevated. Recent news includes a securities fraud investigation announcement and the launch of an FDA-cleared surgical app for Apple Vision Pro.
The outlook for SYK is supported by solid profitability and growth initiatives like acquisitions and product launches, but near-term risks include the fraud investigation and competitive pressures. Analyst consensus is strongly bullish with a $376 price target, suggesting significant upside potential if the company navigates current challenges successfully.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Progressive Corp
Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
